Caris Life Sciences (CAI) Receivables - Net (2024 - 2026)

Caris Life Sciences (CAI) posted quarterly Receivables - Net of $90.5 million for Q1 2026, down 19.28% quarter-over-quarter from $112.1 million in Q4 2025.

Caris Life Sciences (CAI) Receivables - Net (2024 - 2026) Analysis & Trends

Caris Life Sciences' Receivables - Net history runs 3 years deep, the most recent figure standing at $90.5 million for Q1 2026.

  • In Q1 2026, Receivables - Net changed N/A year-over-year to $90.5 million; the TTM figure through Mar 2026 stood at $90.5 million (changed N/A YoY), while the FY2025 annual figure was $112.1 million, up 27.08% from the prior year.
  • Receivables - Net for Q1 2026 stood at $90.5 million, down from $112.1 million in the prior quarter.
  • The five-year high for Receivables - Net was $112.1 million in Q4 2025, with the low at $26.7 million in Q3 2025.
  • The 3-year median for Receivables - Net is $88.2 million (2024), against an average of $73.7 million.
  • Peak annual rise in Receivables - Net reached 27.08% in 2025, while the deepest fall reached 27.08% in 2025.
  • Caris Life Sciences' Receivables - Net stood at $88.2 million in 2024, then grew by 27.08% to $112.1 million in 2025, then slipped by 19.28% to $90.5 million in 2026.
  • Business Quant data shows CAI's Receivables - Net at $90.5 million in Q1 2026, $112.1 million in Q4 2025, and $26.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Caris Life Sciences 6.16 Bn 5.37 Bn 182.38 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 116.89 Mn
Jun 30, 2026 116.89 Mn
Mar 31, 2026 90.52 Mn
Mar 31, 2026 90.52 Mn
Dec 31, 2025 112.14 Mn
Dec 31, 2025 112.14 Mn
Sep 30, 2025 26.70 Mn
Sep 30, 2025 26.70 Mn
Jun 30, 2025 50.89 Mn
Jun 30, 2025 50.89 Mn
Dec 31, 2024 88.24 Mn
Dec 31, 2024 88.24 Mn